BJDX Profile
Bluejay Diagnostics, Inc. is a pioneering diagnostic company focused on advancing the triage, diagnosis, and monitoring of disease progression through innovative technologies. Based in Acton, Massachusetts, the company is dedicated to enhancing patient care with its cutting-edge diagnostic solutions. Bluejay's primary product development revolves around its Symphony platform, a sophisticated technology designed to streamline and improve diagnostic accuracy.
The Symphony platform features the Symphony Fluorescence Immuno-analyzer, which utilizes non-contact centrifugal force to automate blood processing, biomarker isolation, and immunoassay preparation. This high-throughput system aims to provide rapid and precise diagnostic results by integrating these processes into a single, efficient workflow. Complementing this is the Symphony Cartridge Library, which includes a range of reagents and components essential for the platform’s functionality.
Additionally, Bluejay Diagnostics markets the ALLEREYE diagnostic test, a point-of-care (POC) device designed to diagnose allergic conjunctivitis. This test offers clinicians a fast and reliable method for detecting this common eye condition, thereby improving patient management and treatment outcomes. The company is also engaged in developing biomarkers for the detection of various diseases, including hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure.
Bluejay Diagnostics has entered into a strategic license and supply agreement with Toray Industries, Inc., focusing on the production and distribution of protein detection chips, a critical component of its diagnostic technology. Founded in 2015, Bluejay Diagnostics continues to innovate and expand its product offerings, positioning itself at the forefront of diagnostic technology with a commitment to improving healthcare through advanced and reliable diagnostic solutions.
|
